Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.

WASHINGTON, Feb 2 (Reuters) - The Trump administration over the weekend put on administrative leave dozens more staff at U.S. Agency for International Development, three sources familiar with ...

This makes the new indication for Dupixent very important for Sanofi as it searches for a blockbuster to transform its fortunes. The FDA is set to make a decision on Dupixent’s new indication on ...

Am J Health Syst Pharm. 2008;65(24):2347-2357. Administer medications via the oral route when possible. Determine the enteral feeding tube size (e.g., small bore or large bore), insertion site (e ...

Seven-year-old Sajad - whose family were displaced after flooding in Pakistan - is among the millions who have been helped by USAID The future of the US government's main overseas aid agency has ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts ... formulation “by offering a more convenient pre-filled syringe administration, ...